BriaCell Therapeutics Corp (BCTXW) — Cash Flow Reinvestment Rate

Latest as of April 2020: 0.00x

BriaCell Therapeutics Corp (BCTXW) has a Cash Flow Reinvestment Rate of 0.00x as of April 2020, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $60.39K. Explore BriaCell Therapeutics Corp capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$60.39K
USD

Capital Expenditures

$0.00
USD

BriaCell Therapeutics Corp Cash Flow Reinvestment Rate (2006–2006)

Historical reinvestment intensity for BriaCell Therapeutics Corp across 1 annual periods. Also explore BriaCell Therapeutics Corp total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for BriaCell Therapeutics Corp (2006–2006)

Year-by-year capital reinvestment analysis for BriaCell Therapeutics Corp. For live market cap and broader valuation context, see BriaCell Therapeutics Corp (BCTXW) total market value.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2006 0.00x $0.00 $1.13K $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow